Certificate of analysis · ILS Labs
CJC-1295 no DAC + Ipamorelin 10mg, Batch PRIME1026 — Certificate of Analysis
This is the certificate of analysis (COA) that ILS Labs issued for CJC-1295 no DAC + Ipamorelin 10mg, Batch PRIME1026, tested Oct 12, 2026. HPLC purity: 99.94%. Each COA covers one batch.
Key facts
99.94%HPLC purity
Independent third-party lab: ILS Labs
- HPLC purity
- 99.94%
- Lab
- ILS Labs
- Batch / lot
- PRIME1026
- Size
- 10mg
- Test date
- Report number
- COA-2026-7CZ_NQ
- Access code
- JVZPA2D7
- Tests
- Purity, identity and quantity (HPLC) · Fentanyl screen
To check this COA with ILS Labs: open portal.ils-lab.com/verify/b8NxHQInPX6NtVrK and look up report COA-2026-7CZ_NQ with access code JVZPA2D7.
The product
CJC-1295 no DAC + Ipamorelin
View product
Reading this COA
- HPLC purity
- How much of the sample is the stated compound, measured by high-performance liquid chromatography.
- Identity
- Confirms the sample is the compound on the label (LC-MS or HPLC retention time, as the report states).
- Content
- How much compound the vial holds, next to the amount on the label.
Other COAs
- CJC-1295 no DAC + Ipamorelin 20mgBatch PRIME1026 · Oct 12, 202699.91%
- CJC-1295 no DAC + Ipamorelin 10mg, Batch 0426May 29, 202699.248%
- BPC-157 10mgBatch PRIME1026 · Oct 12, 202699.49%
- GLP-2 TZ 10mgBatch PRIME1026 · Oct 12, 202699.90%
- GLP-2 TZ 20mgBatch PRIME1026 · Oct 12, 202699.90%
- GLP-3 RT 20mgBatch PRIME1026 · Oct 12, 202699.90%
COAs are published as the lab issues them. All products are for laboratory research use only.